Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Lymphadenopathy × cabazitaxel × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 4 Neoplasms 2 Recurrence 1 Prostatic Neoplasms, Castration-Resistant 1 Oligodendroglioma 1 Metastatic Castration-resistant Prostate Cancer 1 Malignant Solid Tumor - Malignant Nervous System Neoplasm 1 Lymphadenopathy 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Carcinoma 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

cabazitaxel 1 XRP6258 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01505868 2021-07-30

Cabazitaxel With or Without Carboplatin in Treating Patients With Previously Treated Metastatic Castration-Resistant Prostate Cancer

M.D. Anderson Cancer Center

Phase 1/2 Completed

170 enrolled 22 charts

Lymphadenopathy, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡